Filing Details
- Accession Number:
- 0000028823-17-000114
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-24 16:29:40
- Reporting Period:
- 2017-07-24
- Filing Date:
- 2017-07-24
- Accepted Time:
- 2017-07-24 16:29:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
28823 | Diebold Nixdorf Inc | DBD | Calculating & Accounting Machines (No Electronic Computers) (3578) | 340183970 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1686744 | Jurgen Wunram | C/O Diebold Nixdorf, Incorporated 5995 Mayfair Road North Canton OH 44720 | Svp, Chief Operating Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2017-07-24 | 2,000 | $21.94 | 10,740 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Shares | Non-Qualified Stock Options | $26.60 | 2018-02-08 | 2027-02-07 | 75,356 | 75,356 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2027-02-07 | 75,356 | 75,356 | Direct |
Footnotes
- The aggregate purchase price for the 2,000 Common Shares was 37.693,33 Euros. The purchase price per share in Column 4 of Table I was calculated based on the aggregate purchase price divided by the number of Common Shares purchased. The purchase price per share is shown in U.S. dollars and was converted based on the currency exchange as of the transaction date.
- Number includes restricted stock units.
- Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.